Jeeva's virtual control room helps biopharma and med device sponsors execute modern clinical trials end-to-end with real-time monitoring to achieve greater efficiency, minimize risks, and cut costs with our one-login, one-subscription fee. The platform vastly reduces the logistical burden on both the participant and study team with features such as bi-directional communications, eligibility screening, scheduling, EDC, eCOA, TeleVisits, and remote touch-less electronic informed consent.
The AI-driven Jeeva platform automates and centralizes the schedule of visits and protocol configuration that maps to modules in the platform. Modules include eConsent, ePRO/eCOA/EDC, TeleVisits/VideoVisits, Adverse event capture with MedDRA coding, and patient engagement portal with SMS/email/audio/video communications/reminders/notifications.
The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerate therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates diverse patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device.
Welcome!
